This contract supports the advanced development of promising therapeutic candidates with broad spectrum activity. The research and development activities to be supported will allow candidate therapeutic products to progress through the product development pipeline, and includes preclinical and non-clinical activities, as well as IND development activities.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272201300017C-0-0-1
Application #
8753198
Study Section
Project Start
2013-09-16
Project End
2017-09-15
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$4,996,104
Indirect Cost
Name
Biocryst Pharmaceuticals, Inc.
Department
Type
DUNS #
618194609
City
Durham
State
NC
Country
United States
Zip Code
27703